Precision Cancer Diagnostic Test Market Report 2024-2034

Overall world revenue for Precision Cancer Diagnostic Test Market, 2024 to 2034 in terms of value the market will surpass US$ 12.09 billion in 2024, the work calculates.The author predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Precision Cancer Diagnostic Test Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Adoption of Liquid Biopsies Propels Market Growth

The increasing adoption of liquid biopsies in cancer diagnosis has significantly intensified market competitiveness, with companies actively entering this domain viewed as key drivers of clinical advancements. LabCorp's introduction of a novel blood test in June 2023 for detecting cancer-related biomarkers exemplifies this trend, potentially expediting effective treatments. Liquid biopsy, particularly valuable for those unable to undergo tissue biopsies, is gaining traction, notably in diagnosing advanced and metastatic cancer cases. Breakthroughs, such as the detection of cancer in diverse bodily fluids through liquid biopsy in March 2022, highlight the technology's expanding applications. The ongoing development of non-invasive liquid biopsies focusing on circulating tumor DNA and other markers holds promise for transforming cancer diagnostics by enabling real-time monitoring and early detection. Industry efforts to integrate liquid biopsy with advanced AI technologies, as seen in collaborations like GC Genome Corporation with KAIST, underscore the commitment to enhancing DNA mutation analysis. Noteworthy company initiatives, including Qiagen's acquisition of Verogen and BillionToOne's precise liquid biopsy device launch, highlights the industry's focus on growth, technological advancements, and product innovation, driving market expansion.

Challenges Posed by High Cost of Precision Cancer Diagnostic Test

Precision cancer diagnostic tests utilize advanced technologies, such as next-generation sequencing (NGS) or mass spectrometry, which can be associated with high costs, posing challenges for accessibility, especially in resource-constrained regions. The elevated expenses linked to precision cancer diagnostics may act as a hindrance to market growth, restricting patient access to these advanced diagnostic tools. Despite the significant advantages offered by precision cancer diagnostics, including more accurate diagnoses and personalized treatment plans, the financial implications associated with these tests presents a formidable challenge for both healthcare systems and patients. For example, the FoundationOne CDx, priced at approximately US$5,800.0 per biopsy, delivers valuable information for treatment decisions but can impose a substantial financial burden on patients and healthcare systems. Guardant360, a liquid biopsy test by Guardant Health analyzing circulating tumor DNA, comes with a cost ranging from US$5,000 to US$6,500 per biopsy. While liquid biopsies are less invasive than tissue biopsies, their pricing remains a concern, potentially limiting access for certain patients, particularly those lacking comprehensive insurance coverage, and leading to potential delays in diagnosis and treatment decisions.

What Questions Should You Ask before Buying a Market Research Report?

How is the precision cancer diagnostic test market evolving?
What is driving and restraining the precision cancer diagnostic test market?
How will each precision cancer diagnostic test submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each precision cancer diagnostic test submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading precision cancer diagnostic test markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the precision cancer diagnostic test projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of precision cancer diagnostic test projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the precision cancer diagnostic test market?
Where is the precision cancer diagnostic test market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the precision cancer diagnostic test market today, and over the next 10 years:

The 370-page report provides 135 tables and 235 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them – NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the precision cancer diagnostic test market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising precision cancer diagnostic test prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product & Services Outlook

Products
Services

Test Type

Cancer Imaging
Computed Tomography
Magnetic Resonance Imaging
Digital & Analog Mammography
Positron Emission Tomography
Digital Breast Tomosynthesis
Molecular Breast Imaging
Others
Molecular Cancer Testing
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Liquid Biopsies
Immunohistochemistry (IHC)
Fluorescence In Situ Hybridization (FISH)
Others
Tumour Marker Immunoassays
POC Colon Cancer Tests
Others

Biopsy Method

Liquid Biopsy
Tissue Biopsy

Application

Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Pancreatic Cancer
Other Cancers

End-user

Diagnostic Laboratories
Hospitals
Cancer Centers and Clinics
Research Institutions

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

U.S.
Canada

Europe

Germany
UK
France
Spain
Italy
Russia
Rest of Europe

Asia Pacific

China
Japan
India
Australia
South Korea
Rest of Asia Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

MEA

GCC
South Africa
Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Cancer Diagnostic Test Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

Abbott
Agilent Technologies, Inc.
Bayer AG
bioMérieux SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Myriad Genetics, Inc.
QIAGEN N.V.
Siemens Healthineers
Thermo Fisher Scientific

How will the Precision Cancer Diagnostic Test Market, 2024 to 2034 report help you?

In summary, the 370-page report provides you with the following knowledge:

Revenue forecasts to 2034 for Precision Cancer Diagnostic Test Market, 2024 to 2034 Market, with forecasts for product, test type, application, biopsy method, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 18 key national markets – See forecasts for the Precision Cancer Diagnostic Test Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Precision Cancer Diagnostic Test Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Precision Cancer Diagnostic Test Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

1 Report Overview

1.1 Objectives of the Study
1.2 Introduction to Precision Cancer Diagnostic Test Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher

2 Executive Summary

3 Market Overview

3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Advancements in Genomic Research
3.2.1.2 High Demand for Personalized Healthcare
3.2.1.3 Rising Prevalence of Cancer
3.2.2 Market Restraining Factors
3.2.2.1 Regulatory Hurdles
3.2.2.2High Cost of Precision Cancer Diagnostic Tests
3.2.3 Market Opportunities
3.2.3.1 Integration of AI and Machine Learning for Cancer Diagnosis
3.2.3.2 Rising Adoption of Liquid Biopsies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Precision Cancer Diagnostic Test Market Analysis by Products & Services

4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
4.4 Products
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Services
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Precision Cancer Diagnostic Test Market Analysis by Test Type

5.1 Key Findings
5.2 Test Type Segment: Market Attractiveness Index
5.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
5.4 Cancer Imaging
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.4.3 Computed Tomography
5.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.3.2 Market Share by Region, 2024 & 2034 (%)
5.4.4 Magnetic Resonance Imaging
5.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.4.2 Market Share by Region, 2024 & 2034 (%)
5.4.5 Digital & Analog Mammography
5.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.5.2 Market Share by Region, 2024 & 2034 (%)
5.4.6 Positron Emission Tomography
5.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.6.2 Market Share by Region, 2024 & 2034 (%)
5.4.7 Digital Breast Tomosynthesis
5.4.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.7.2 Market Share by Region, 2024 & 2034 (%)
5.4.8 Molecular Breast Imaging
5.4.8.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.8.2 Market Share by Region, 2024 & 2034 (%)
5.4.9 Others
5.4.9.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.9.2 Market Share by Region, 2024 & 2034 (%)
5.5 Molecular Cancer Testing
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.5.3 Polymerase Chain Reaction (PCR)
5.5.3.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.3.2 Market Share by Region, 2024 & 2034 (%)
5.5.4 Next-Generation Sequencing (NGS)
5.5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5.5 Liquid Biopsies
5.5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.5.2 Market Share by Region, 2024 & 2034 (%)
5.5.6 Immunohistochemistry (IHC)
5.5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.6.2 Market Share by Region, 2024 & 2034 (%)
5.5.7 Fluorescence In Situ Hybridization (FISH)
5.5.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.7.2 Market Share by Region, 2024 & 2034 (%)
5.5.8 Others
5.5.8.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.8.2 Market Share by Region, 2024 & 2034 (%)
5.6 Tumour Marker Immunoassays
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 POC Colon Cancer Tests
5.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Others
5.8.1 Market Size by Region, 2024-2034 (US$ Million)
5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Precision Cancer Diagnostic Test Market Analysis by Application

6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
6.4 Breast Cancer
6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Lung Cancer
6.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Colorectal Cancer
6.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Melanoma
6.7.1 Market Size by Region, 2024-2034 (US$ Million)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Pancreatic Cancer
6.8.1 Market Size by Region, 2024-2034 (US$ Million)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Other Cancers
6.9.1 Market Size by Region, 2024-2034 (US$ Million)
6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Precision Cancer Diagnostic Test Market Analysis by Biopsy Method

7.1 Key Findings
7.2 Biopsy Method Segment: Market Attractiveness Index
7.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
7.4 Liquid Biopsy
7.4.1 Market Size by Region, 2024-2034 (US$ Million)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Tissue Biopsy
7.5.1 Market Size by Region, 2024-2034 (US$ Million)
7.5.2 Market Share by Region, 2024 & 2034 (%)

8 Precision Cancer Diagnostic Test Market Analysis by End-user

8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
8.4 Diagnostic Laboratories
8.4.1 Market Size by Region, 2024-2034 (US$ Million)
8.4.2 Market Share by Region, 2024 & 2034 (%)
8.5 Hospitals
8.5.1 Market Size by Region, 2024-2034 (US$ Million)
8.5.2 Market Share by Region, 2024 & 2034 (%)
8.6 Cancer Centers and Clinics
8.6.1 Market Size by Region, 2024-2034 (US$ Million)
8.6.2 Market Share by Region, 2024 & 2034 (%)
8.7 Research Institutions
8.7.1 Market Size by Region, 2024-2034 (US$ Million)
8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Precision Cancer Diagnostic Test Market Analysis by Region

9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Precision Cancer Diagnostic Test Market Analysis

10.1 Key Findings
10.2 North America Precision Cancer Diagnostic Test Market Attractiveness Index
10.3 North America Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
10.4 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
10.5 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
10.6 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
10.6.1 North America Cancer Imaging Market Size Estimation and Forecast by Type
10.6.2 North America Molecular Cancer Testing Market Size Estimation and Forecast by Type
10.7 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
10.8 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
10.9 North America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
10.10 U.S. Precision Cancer Diagnostic Test Market Analysis
10.11 Canada Precision Cancer Diagnostic Test Market Analysis

11 Europe Precision Cancer Diagnostic Test Market Analysis

11.1 Key Findings
11.2 Europe Precision Cancer Diagnostic Test Market Attractiveness Index
11.3 Europe Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
11.5 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
11.6 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
11.6.1 Europe Cancer Imaging Market Size Estimation and Forecast by Type
11.6.2 Europe Molecular Cancer Testing Market Size Estimation and Forecast by Type
11.7 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
11.8 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
11.9 Europe Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
11.10 Germany Precision Cancer Diagnostic Test Market Analysis
11.11 UK Precision Cancer Diagnostic Test Market Analysis
11.12 France Precision Cancer Diagnostic Test Market Analysis
11.13 Italy Precision Cancer Diagnostic Test Market Analysis
11.14 Spain Precision Cancer Diagnostic Test Market Analysis
11.15 Russia Precision Cancer Diagnostic Test Market Analysis
11.16 Rest of Europe Precision Cancer Diagnostic Test Market Analysis

12 Asia Precision Cancer Diagnostic Test Market Analysis

12.1 Key Findings
12.2 Asia Precision Cancer Diagnostic Test Market Attractiveness Index
12.3 Asia Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
12.4 Asia Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
12.5 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
12.6 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
12.6.1 Asia Pacific Cancer Imaging Market Size Estimation and Forecast by Type
12.6.2 Asia Pacific Molecular Cancer Testing Market Size Estimation and Forecast by Type
12.7 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
12.8 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
12.9 Asia Pacific Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
12.10Japan Precision Cancer Diagnostic Test Market Analysis
12.11China Precision Cancer Diagnostic Test Market Analysis
12.12India Precision Cancer Diagnostic Test Market Analysis
12.13Australia Precision Cancer Diagnostic Test Market Analysis
12.14South Korea Precision Cancer Diagnostic Test Market Analysis
12.15Rest of Asia Precision Cancer Diagnostic Test Market Analysis

13 Latin America Precision Cancer Diagnostic Test Market Analysis

13.1 Key Findings
13.2 Latin America Precision Cancer Diagnostic Test Market Attractiveness Index
13.3 Latin America Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
13.4 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
13.5 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
13.6 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
13.6.1 Latin America Cancer Imaging Market Size Estimation and Forecast by Type
13.6.2 Latin America Molecular Cancer Testing Market Size Estimation and Forecast by Type
13.7 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
13.8 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
13.9 Latin America Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
13.10Brazil Precision Cancer Diagnostic Test Market Analysis
13.11Mexico Precision Cancer Diagnostic Test Market Analysis
13.12Argentina Precision Cancer Diagnostic Test Market Analysis
13.13Rest of Latin America Precision Cancer Diagnostic Test Market Analysis

14 MEA Precision Cancer Diagnostic Test Market Analysis

14.1 Key Findings
14.2 MEA Precision Cancer Diagnostic Test Market Attractiveness Index
14.3 MEA Precision Cancer Diagnostic Test Market by Country, 2024, 2029 & 2034 (US$ Million)
14.4 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Country
14.5 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Products & Services
14.6 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Test Type
14.6.1 MEA Cancer Imaging Market Size Estimation and Forecast by Type
14.6.2 MEA Molecular Cancer Testing Market Size Estimation and Forecast by Type
14.7 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Application
14.8 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by Biopsy Method
14.9 MEA Precision Cancer Diagnostic Test Market Size Estimation and Forecast by End-user
14.10 GCC Precision Cancer Diagnostic Test Market Analysis
14.11 South Africa Precision Cancer Diagnostic Test Market Analysis
14.12 Rest of MEA Precision Cancer Diagnostic Test Market Analysis

15 Company Profiles

15.1 Company Share Analysis, 2023
15.2 Strategic Outlook
15.3 F. Hoffmann-La Roche Ltd.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2022
15.3.3.2 R&D, 2017-2022
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Illumina, Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2022
15.4.3.2 R&D, 2017-2022
15.4.3.3 Regional Market Shares, 2022
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Abbott
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2022
15.5.3.2 R&D, 2017-2022
15.5.3.3 Regional Market Shares, 2022
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 QIAGEN N.V.
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2022
15.6.3.2 R&D, 2017-2022
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Thermo Fisher Scientific
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2022
15.7.3.2 R&D, 2017-2022
15.7.3.3 Regional Market Shares, 2022
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 bioMérieux SA
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2022
15.8.3.2 R&D, 2017-2022
15.8.3.3 Regional Market Shares, 2022
15.8.4 Product Benchmarking
15.9 Siemens Healthineers
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2022
15.9.3.2 R&D, 2017-2022
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Bayer AG
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2022
15.10.3.2 R&D, 2017-2022
15.10.3.3 Regional Market Shares, 2022
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Myriad Genetics, Inc.
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2022
15.11.3.2 R&D, 2017-2022
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Agilent Technologies, Inc.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2017-2022
15.12.3.2 R&D, 2017-2022
15.12.3.3 Regional Market Shares, 2022
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook

16 Conclusion and Recommendations

16.1 Concluding Remarks from the Publisher
16.2 Recommendations for Market Players

List of Tables

Table 1 Precision Cancer Diagnostic Test Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 7 Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 8 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 9 Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 10 Cancer Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 11 Computed Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 12 Magnetic Resonance Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 13 Digital & Analog Mammography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 14 Positron Emission Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 15 Digital Breast Tomosynthesis Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 16 Molecular Breast Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 17 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 18 Molecular Cancer Testing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Polymerase Chain Reaction (PCR) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 20 Next-Generation Sequencing (NGS) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 21 Liquid Biopsies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 22 Immunohistochemistry (IHC) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 23 Fluorescence In Situ Hybridization (FISH) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 25 Tumour Marker Immunoassays Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 26 POC Colon Cancer Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 28 Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 29 Breast Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 30 Lung Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 31 Colorectal Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 32 Melanoma Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 33 Pancreatic Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Other Cancers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 35 Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 36 Liquid Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 37 Tissue Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 38 Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 39 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 40 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 41 Cancer Centers and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 42 Research Institutions Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 43 Precision Cancer Diagnostic Test Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 44 North America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 North America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 46 North America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 47 North America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 48 North America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 49 North America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 50 North America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 51 North America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 52 U.S. Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 53 Canada Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 54 Europe Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 55 Europe Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 56 Europe Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Europe Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 58 Europe Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Europe Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 60 Europe Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 61 Europe Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 62 Germany Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 63 UK Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 64 France Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 Italy Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 66 Spain Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 67 Russia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 68 Rest of Europe Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 69 Asia Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 70 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 71 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 Asia Pacific Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 73 Asia Pacific Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 74 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 75 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 76 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 77 Japan Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 78 China Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 79 India Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 80 Australia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 81 South Korea Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 82 Rest of Asia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 83 Latin America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 84 Latin America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 85 Latin America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 86 Latin America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 87 Latin America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 88 Latin America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 89 Latin America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 90 Latin America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 91 Brazil Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 92 Mexico Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 93 Argentina Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 94 Rest of Latin America Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 95 MEA Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 96 MEA Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 97 MEA Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 98 MEA Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 99 MEA Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 100 MEA Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 101 MEA Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 102 MEA Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 103 GCC Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 104 South Africa Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 105 Rest of MEA Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 106 Strategic Outlook
Table 107 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 109 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 110 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Illumina, Inc.: Product Benchmarking
Table 112 Illumina, Inc.: Strategic Outlook
Table 113 Abbott.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Abbott: Product Benchmarking
Table 115 Abbott.: Strategic Outlook
Table 116 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Qiagen N.V.: Product Benchmarking
Table 118 Qiagen N.V.: Strategic Outlook
Table 119 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Thermo Fisher Scientific: Product Benchmarking
Table 121 Thermo Fisher Scientific: Strategic Outlook
Table 122 bioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 BioMerieux SA: Product Benchmarking
Table 124 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Canon Medical Systems Corporation: Product Benchmarking
Table 126 Siemens: Strategic Outlook
Table 127 Bayer AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Bayer AG: Product Benchmarking
Table 129 Bayer AG: Strategic Outlook
Table 130 Myriad Genetics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Myriad Genetics, Inc: Product Benchmarking
Table 132 Myriad Genetics: Strategic Outlook
Table 133 Agilent Technologies, Inc..: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Agilent Technologies, Inc.: Product Benchmarking
Table 135 Agilent Technologies, Inc.: Strategic Outlook

List of Figures

Figure 1 Precision Cancer Diagnostic Test Market Segmentation
Figure 2 Precision Cancer Diagnostic Test Market by Products & Services: Market Attractiveness Index
Figure 3 Precision Cancer Diagnostic Test Market by Test Type: Market Attractiveness Index
Figure 4 Precision Cancer Diagnostic Test Market by Application: Market Attractiveness Index
Figure 5 Precision Cancer Diagnostic Test Market by Biopsy Method: Market Attractiveness Index
Figure 6 Precision Cancer Diagnostic Test Market by End-user: Market Attractiveness Index
Figure 7 Precision Cancer Diagnostic Test Market Attractiveness Index by Region
Figure 8 Precision Cancer Diagnostic Test Market: Market Dynamics
Figure 9 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): “V” Shaped Recovery
Figure 10 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): “U” Shaped Recovery
Figure 11 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): “W” Shaped Recovery
Figure 12 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %): “L” Shaped Recovery
Figure 13 Precision Cancer Diagnostic Test Market: Porter’s Five Forces Analysis
Figure 14 Precision Cancer Diagnostic Test Market: PEST Analysis
Figure 15 Precision Cancer Diagnostic Test Market by Products & Services: Market Attractiveness Index
Figure 16 Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
Figure 17 Precision Cancer Diagnostic Test Share Forecast by Products & Services, 2024, 2029, 2034 (%)
Figure 18 Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 19 Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Services Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 21 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Precision Cancer Diagnostic Test Market by Test Type: Market Attractiveness Index
Figure 23 Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
Figure 24 Precision Cancer Diagnostic Test Share Forecast by Test Type, 2024, 2029, 2034 (%)
Figure 25 Cancer Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 26 Cancer Imaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Computed Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 28 Computed Tomography Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Magnetic Resonance Imaging (MRI) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 30 Magnetic Resonance Imaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Digital & Analog Mammography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 32 Digital & Analog Mammography Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Positron Emission Tomography Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 34 Positron Emission Tomography Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Digital Breast Tomosynthesis Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 36 Digital Breast Tomosynthesis Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Molecular Breast Imaging Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 38 Molecular Breast Imaging Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Molecular Cancer Testing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 42 Molecular Cancer Testing Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Polymerase Chain Reaction (PCR) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 44 Polymerase Chain Reaction (PCR) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Next-Generation Sequencing (NGS) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 46 Next-Generation Sequencing (NGS) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Liquid Biopsies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 48 Liquid Biopsies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Immunohistochemistry (IHC) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 50 Immunohistochemistry (IHC) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Fluorescence In Situ Hybridization (FISH) Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 52 Fluorescence In Situ Hybridization (FISH) Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 54 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Tumour Marker Immunoassays Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 56 Tumour Marker Immunoassays Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 57 POC Colon Cancer Tests Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 58 POC Colon Cancer Tests Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 59 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 61 Precision Cancer Diagnostic Test Market by Application: Market Attractiveness Index
Figure 62 Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 63 Precision Cancer Diagnostic Test Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 64 Breast Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 65 Breast Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 66 Lung Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 67 Lung Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 68 Colorectal Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 69 Colorectal Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 70 Melanoma Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 71 Melanoma Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Pancreatic Cancer Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 73 Pancreatic Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 74 Other Cancers Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 75 Other Cancers Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 76 Precision Cancer Diagnostic Test Market by Biopsy Method: Market Attractiveness Index
Figure 77 Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
Figure 78 Precision Cancer Diagnostic Test Share Forecast by Biopsy Method, 2024, 2029, 2034 (%)
Figure 79 Liquid Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 80 Liquid Biopsy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 81 Tissue Biopsy Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 82 Tissue Biopsy Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 83 Precision Cancer Diagnostic Test Market by End-user: Market Attractiveness Index
Figure 84 Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 85 Precision Cancer Diagnostic Test Share Forecast by End-user, 2024, 2029, 2034 (%)
Figure 86 Diagnostic Laboratories Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 87 Diagnostic Laboratories Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 88 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 89 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 90 Cancer Centers and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 91 Cancer Centers and Clinics Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 92 Research Institutions Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 93 Research Institutions Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 94 Precision Cancer Diagnostic Test Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 95 Precision Cancer Diagnostic Test Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 96 Precision Cancer Diagnostic Test Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 97 North America Precision Cancer Diagnostic Test Market Attractiveness Index
Figure 98 North America Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$Million)
Figure 99 North America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 100 North America Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
Figure 101 North America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
Figure 102 North America Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
Figure 103 North America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
Figure 104 North America Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
Figure 105 North America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 106 North America Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
Figure 107 North America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 108 North America Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 109 North America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 110 North America Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
Figure 111 North America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
Figure 112 North America Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
Figure 113 North America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 114 North America Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 115 U.S. Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 116 Canada Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 117 Europe Precision Cancer Diagnostic Test Market Attractiveness Index
Figure 118 Europe Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 119 Europe Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 120 Europe Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
Figure 121 Europe Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
Figure 122 Europe Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
Figure 123 Europe Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
Figure 124 Europe Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
Figure 125 Europe Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 126 Europe Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
Figure 127 Europe Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 128 Europe Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 129 Europe Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 130 Europe Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
Figure 131 Europe Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
Figure 132 Europe Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
Figure 133 Europe Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 134 Europe Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 135 Germany Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 136 UK Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 137 France Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 138 Italy Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 139 Spain Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 140 Russia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 141 Rest of Europe Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 142 Asia Precision Cancer Diagnostic Test Market Attractiveness Index
Figure 143 Asia Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 144 Asia Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 145 Asia Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
Figure 146 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
Figure 147 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
Figure 148 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
Figure 149 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
Figure 150 Asia Pacific Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 151 Asia Pacific Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
Figure 152 Asia Pacific Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 153 Asia Pacific Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 154 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 155 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
Figure 156 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
Figure 157 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
Figure 158 Asia Pacific Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 159 Asia Pacific Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 160 Japan Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 161 China Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 162 India Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 163 Australia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 164 South Korea Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 165 Rest of Asia Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 166 Latin America Precision Cancer Diagnostic Test Market Attractiveness Index
Figure 167 Latin America Precision Cancer Diagnostic Test Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 168 Latin America Precision Cancer Diagnostic Test Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 169 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Country, 2024 & 2034 (%)
Figure 170 Latin America Precision Cancer Diagnostic Test Market Forecast by Products & Services, 2024-2034 (US$ Million, AGR %)
Figure 171 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Products & Services, 2024 & 2034 (%)
Figure 172 Latin America Precision Cancer Diagnostic Test Market Forecast by Test Type, 2024-2034 (US$ Million, AGR %)
Figure 173 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Test Type, 2024 & 2034 (%)
Figure 174 Latin America Cancer Imaging Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 175 Latin America Cancer Imaging Market Share Forecast by Type, 2024 & 2034 (%)
Figure 176 Latin America Molecular Cancer Testing Market Forecast by Type, 2024-2034 (US$ Million, AGR %)
Figure 177 Latin America Molecular Cancer Testing Market Share Forecast by Type, 2024 & 2034 (%)
Figure 178 Latin America Precision Cancer Diagnostic Test Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 179 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Application, 2024 & 2034 (%)
Figure 180 Latin America Precision Cancer Diagnostic Test Market Forecast by Biopsy Method, 2024-2034 (US$ Million, AGR %)
Figure 181 Latin America Precision Cancer Diagnostic Test Market Share Forecast by Biopsy Method, 2024 & 2034 (%)
Figure 182 Latin America Precision Cancer Diagnostic Test Market Forecast by End-user, 2024-2034 (US$ Million, AGR %)
Figure 183 Latin America Precision Cancer Diagnostic Test Market Share Forecast by End-user, 2024 & 2034 (%)
Figure 184 Brazil Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 185 Mexico Precision Cancer Diagnostic Test Market Forecast, 2024-2034 (US$ Million, AGR %)

Companies Mentioned

Abbott
Agilent Technologies, Inc.
Bayer AG
bioMérieux SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Myriad Genetics, Inc.
QIAGEN N.V.
Siemens Healthineers
Thermo Fisher Scientific
7D Surgical
Agendia N.V.
AmoyDx
AstraZeneca
Biognosys
Boehringer Ingelheim
BostonGene
Cell Signaling Technology (CST)
Cytognos
Dako
Dilon Technologies
Exact Sciences
Foundation Medicine
Gamma Medica
GeneoDx
Geneseeq Technology Inc
Genetron Holdings
Genome Insight
Grail
GRAIL
Guardant Health
Hologic
IBM Watson Health
Intelliseq
Janssen Biotech Inc.
Lifebit
MiMARK Diagnostics
Nanostics Inc.
Nashville Biosciences LLC
NeoGenomics
NGeneBio
Novartis
Omica.bio
Oncgnostics GmbH
Oncoclínicas & Co.
PathAI
PathCare
Pfizer
Philips
Pillar Biosciences Inc.
PreCheck Health Services Inc.
Roche Diagnostics Korea
Sonic Healthcare
SSM Health
Sysmex
American Cancer Society (ACS)
Brain Cancer Canada
Brand Equity Foundation
Brazilian Ministry of Health
Breastcancer.org
Cancer Association of South Africa (CANSA)
Cancer Awareness Prevention and Early Detection Trust (CAPED)
Cancer Council Australia
Cancer Genome Atlas (TCGA)
Cancer Hospital
Chinese Academy of Medical Sciences (CAMS)
Chinese National Medical Products Administration (NMPA)
Clermont-Ferrand University Hospital
Dana-Farber Cancer Institute
Dante Labs and Government, Italy
Douglass Hanly Moir Pathology
Dubai Health Authority
Engineering and Physical Sciences Research Council
ETH Zürich
European Commission
European Union
Foundation Medicine
French Government
French National Agency for the Safety of Medicines and Health Products (ANSM)
Garvan Institute of Medical Research
Genetic Health Queensland
German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ)
Health Department at the University of South Alabama (USA Health)
Health Sciences Authority (HSA), Singapore
High Health Authority (HAS)
Hospital Israelita Albert Einstein
Hudson Institute of Medical Research
Institute for Quality and Efficiency in Health Care (IQWiG)
Institute Gustave Roussy
International Agency for Research on Cancer
International Agency for Research on Cancer (IARC)
International Collaborative Member of Dana-Farber Cancer Institute
Italian Association for Cancer Research (Associazione Italiana per la Ricerca sul Cancro, or AIRC)
Jean Perrin Centre
King Fahad Medical City, Saudi Arabia
Ministry of Health and Family Welfare
National Agency for the Promotion of Science and Technology (ANPCyT)
National Cancer Center Hospital, Japan
National Cancer Centre Hospital East, Japan
National Cancer Institute (NCI)
National Center for Biotechnology Information (NCBI)
Oncoclínicas Cancer Centre
Ontario Institute for Cancer Research (OICR)
Peter MacCallum Cancer Centre
Royal Marsden NHS Foundation Trust
Russian Federation
Sbarro Health Research Organization (SHRO)
Seoul National University Hospital
St. Michael's Hospital
U.S. Preventive Services Task Force (USPSTF)
UK Research and Innovation
University of Tokyo Hospital
Vanderbilt University Medical Center (VUMC)
Victorian Comprehensive Cancer Centre (VCCC)
World Bank
World Cancer Research Fund International
World Health Organization (WHO)

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€6795EUR$7,198USD£5,481GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€8045EUR$8,522USD£6,489GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€9451EUR$10,011USD£7,623GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€11943EUR$12,651USD£9,633GBP